Advertisement admin, Author at Pharmaceutical Business review - Page 405 of 458
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by Lavillcok Lavillcok

Basilea begins BAL30072 pharmacokinetic Phase 1 study

The injectable sulfactam antibiotic has the potential to target clinically relevant gram-negative bacteria resistant to multiple drugs including Pseudomonas or Acinetobacter species. Basilea chief medical officer Prof. Achim